Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Marrow protein may be key to SCT success

    ... cells more rapidly. In addition, people undergoing chemotherapy who develop febrile neutropenia , associated with low ...

    Article last updated 08/29/2017 - 11:18am.

  2. Chemotherapy

    ... this from happening, your doctor may prescribe intensive chemotherapy in order to kill bone marrow cells that have an abnormal size, shape, or look. Chemotherapy for MDS patients involves the use of medicines that kill cells, ...

    Page last updated 01/20/2015 - 4:45pm.

  3. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    ... Treatment with other investigational agents including chemotherapy , immunotherapy, or radiation therapy within a month prior to ... Day 1 or who has not recovered (i.e., Has had prior chemotherapy, targeted small molecule therapy, or radiation therapy within 2 ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  4. Barry Gore

    ... every month, he needs to have five consecutive days of chemotherapy and suffer the intense intestinal side effects that go along ... Links Chemotherapy Bone Marrow Biopsy (Diagnosis) ...

    "Like You" Patient Story last updated 04/26/2018 - 3:09pm.

  5. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

    ... rendering them unsuitable for intensive induction chemotherapy or transplantation. We report preliminary cellular immune ...

    Research Article last updated 05/22/2017 - 11:42am.

  6. Oncologists tell the backstory of informed consent

    ... like to treat you with two, or three, or four different chemotherapy drugs, each of which has distinct side effects, some of which ... find comfort in handing decisions about interventions like chemotherapy or heart surgery over to another. We tell our patients that if it ...

    Article last updated 03/02/2017 - 10:03am.

  7. A Phase 1b/2 Study to Evaluate the Safety and Efficacy of APR-246 in Combination with Azacitidine for the Treatment of TP53 Mutant Myeloid Neoplasms

    ... intrauterine device or double barrier method during chemotherapy treatment and for at least six months thereafter. ...

    Clinical Trial last updated 04/21/2018 - 6:04pm.

  8. Overcoming age barrier to transplantation

    ... toward improved methods of surgery, radiation, and chemotherapy in hopes of slowing or eradicating cancer's spread. And we've ...

    Article last updated 04/03/2017 - 2:00pm.

  9. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... study b.         Eligible to receive induction chemotherapy , such as 7-10 days of cytosine arabinoside and 2-3 days of an ... Any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy, or corticosteroids ( ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  10. Builds supportive community to help him with MDS and bone marrow transplant

    ... The first eight days of Duane’s treatment consisted of chemotherapy sessions to destroy his own bone marrow . During this ...

    Patient Chronicle last updated 04/26/2018 - 10:50am.